SUTTER ROCK CAPITAL CORP SSSS 深 沪
已收盘 06-30 16:00:00 美东时间
12.54
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 12.54
- 总市值 3.27亿
- 52周最高 14.9799
- 市盈率 静 7.40
- 换手率 0.00%
- 52周最低 7.6606
- 委 比 0.00%
- 总股本 2607.02万
- 历史最高 14.9799
- 量 比 0
- 振 幅 0.00%
- 历史最低 -5.88
- 每 手 1
- 风险率 1.89%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股收盘：美伊和平协议预期持续升温！三大指数周均累涨约0.7%；SpaceX上市首日涨19%，总市值2.1万亿美元
美伊和平协议预期持续升温！三大指数周均累涨约0.7%；SpaceX上市首日涨19%，总市值2.1万亿美元；太空概念股大跌，维珍银河跌超31%；存储概念股走强，闪迪涨超5%>>
06-13 09:07
SuRo Capital shareholders approve Neostellar Advisors investment advisory agreement
SuRo Capital shareholders approve Neostellar Advisors investment advisory agreement SuRo Capital held its annual shareholder meeting on June 10, 2026, backing the selection of CBIZ CPAs P.C. as auditor for 2026. Shareholders also ratified a board slate, returning Mark D. Klein and Lisa Westley to th
06-12 19:31
Graham, Appian And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures rise, Nasdaq up 1%. Graham Corp shares down 8.7%. Other stocks declining in pre-market trading: BVC, TLK, INDP, APPN, WIX, KB, SSSS, IPSC, AMPL, ICCM, SBSW, ROMA.
06-08 20:04
美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
Barrington Research Maintains Outperform on SuRo Capital, Raises Price Target to $18
Barrington Research analyst Alexander Paris maintains SuRo Capital (NASDAQ:SSSS) with a Outperform and raises the price target from $17 to $18.
05-07 06:49
CORRECTION: SuRo Capital Q1 EPS $(0.16) Misses $(0.14) Estimate, Sales $731.963K Beat $405.500K Estimate
SuRo Capital (NASDAQ:SSSS) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.14) by 14.29 percent. This is unchanged from the same period last year. The company reported
05-06 06:15
SuRo Capital Reports Q1 2026 Results: Full Earnings Call Transcript
SuRo Capital (NASDAQ:SSSS) released first-quarter financial results and hosted ...
05-06 05:59
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
CoreWeave's 50% Stock Jump Isn't The Peak — This Expert Says More Is Coming
CoreWeave stock has surged 50% in April, but SuRo Capital CEO Mark Klein says the AI infrastructure play still has more room to run.
04-20 20:09
